Cargando…

“Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector

Detalles Bibliográficos
Autores principales:	Farshchi, Amir, Kebriaeezadeh, Abbas, Dinarvand, Rassoul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277613/ https://www.ncbi.nlm.nih.gov/pubmed/25561906

Ejemplares similares

SPER 3(rd) annual conference on “Recent trends in pharma industry: Bridging the gaps in pharmaceutical education”
por: Nagaich, Upendra
Publicado: (2014)

Consistent defined threshold and equity in health
por: Nikfar, Shekoufeh, et al.
Publicado: (2015)

SPER 1(st) Annual Conference on “PharmaVision: Raising awareness towards recent advancement in pharmaceutical research”
por: Nagaich, Upendra
Publicado: (2012)

Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods
por: Jaberidoost, Mona, et al.
Publicado: (2015)

A model for developing a decision support system to simulate national drug policy indicators
por: Abdollahiasl, Akbar, et al.
Publicado: (2011)

Blockchain Powered Vaccine Efficacy for Pharma Sector
por: Sharmila,, et al.
Publicado: (2022)

Bioactive Formulations in Agri-Food-Pharma: Source and Applications
por: Sridhar, Kandi, et al.
Publicado: (2023)

Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
por: Saremi, Shahrooz, et al.
Publicado: (2013)

A system dynamics model for national drug policy
por: Abdollahiasl, Akbar, et al.
Publicado: (2014)

Bio-Based Formulations for Sustainable Applications in Agri-Food-Pharma
por: Sharma, Minaxi, et al.
Publicado: (2021)

Antioxidant Phytochemicals at the Pharma-Nutrition Interface
por: Azzini, Elena, et al.
Publicado: (2017)

Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study
por: Ebadi Fardazar, Farbod, et al.
Publicado: (2019)

PharmaNet: Pharmaceutical discovery with deep recurrent neural networks
por: Ruiz Puentes, Paola, et al.
Publicado: (2021)

The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus
por: Farshchi, Amir, et al.
Publicado: (2014)

Pharmaceutical supply chain risks: a systematic review
por: Jaberidoost, Mona, et al.
Publicado: (2013)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014)

BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management
por: Rodwin, Victor G., et al.
Publicado: (2018)

Pharma-Ecology – The Occurrence and Fate of Pharmaceuticals and Personal Care Products in the Environment
por: Halden, Rolf U.
Publicado: (2009)

The Pharma-Nutritional Role of Antioxidant Phytochemicals in Health and Disease
por: Davinelli, Sergio, et al.
Publicado: (2022)

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
por: Annabi, Majid, et al.
Publicado: (2017)

BigPharma and unethical marketing of medicinal products
por: Myhr, Kirsten
Publicado: (2011)

Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis
por: Varmaghani, Mehdi, et al.
Publicado: (2015)

The Image of Pharma
Publicado: (2007)

Pharma-Ecology
por: Jjemba, Patrick
Publicado: (2018)

Nanoparticles for Targeted Delivery of Active Agents against Tumor Cells
por: Dinarvand, Rassoul, et al.
Publicado: (2012)

Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
por: Luque, Rafael, et al.
Publicado: (2021)

Qualitative analysis of national documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran
por: Bastani, Peivand, et al.
Publicado: (2018)

Big Pharma (The Play)
por: Bero, Lisa
Publicado: (2007)

Deciding priorities in Pharma
por: Koehler, Maria
Publicado: (2010)

DrugMAP: molecular atlas and pharma-information of all drugs
por: Li, Fengcheng, et al.
Publicado: (2022)

Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry
por: Bartfai, Tamas, et al.
Publicado: (2011)

Pharma 4.0: analysis on core competence and digital levelling implementation in pharmaceutical industry in Indonesia
por: Nurlaela Arief, N., et al.
Publicado: (2022)

Implementation of Quantitative and Systems Pharmacology in Large Pharma
por: Visser, S A G, et al.
Publicado: (2014)

Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods
por: Tahmasebi, Nima, et al.
Publicado: (2015)

Health sector leadership to strengthen civil registration and vital statistics systems
por: Lopez, Alan D
Publicado: (2023)

Transformation of Agro-Waste into Value-Added Bioproducts and Bioactive Compounds: Micro/Nano Formulations and Application in the Agri-Food-Pharma Sector
por: Bala, Saroj, et al.
Publicado: (2023)

Impact of Corporate Reputation on Brand Differentiation: An Empirical Study from Iranian Pharmaceutical Companies
por: vahabzadeh, Afshin, et al.
Publicado: (2017)

Pharma Websites and “Professionals-Only” Information: The Implications for Patient Trust and Autonomy
por: Graber, Mark Alan, et al.
Publicado: (2017)

Global Pharma: Managing Uncertainty
por: Munson, Chuck
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3caaq6271cfo2c1kkrac06c3h9